A Study of Retinal Imaging to Detect Abnormal Protein Deposits Associated With Alzheimer's Disease
Clinical trial NCT07254234 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07254234
- Sponsor
- Eli Lilly and Company
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-12-01
- Primary completion
- 2026-08-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.